DE60239386D1 - Zellbibliothek - Google Patents

Zellbibliothek

Info

Publication number
DE60239386D1
DE60239386D1 DE60239386T DE60239386T DE60239386D1 DE 60239386 D1 DE60239386 D1 DE 60239386D1 DE 60239386 T DE60239386 T DE 60239386T DE 60239386 T DE60239386 T DE 60239386T DE 60239386 D1 DE60239386 D1 DE 60239386D1
Authority
DE
Germany
Prior art keywords
novel
libraries
host cells
cell library
discovery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60239386T
Other languages
English (en)
Inventor
Neil Goldsmith
Alexandra M Sorensen
Soren V Nielsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Evolva Holding SA
Original Assignee
Evolva AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evolva AG filed Critical Evolva AG
Application granted granted Critical
Publication of DE60239386D1 publication Critical patent/DE60239386D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
DE60239386T 2001-01-25 2002-01-25 Zellbibliothek Expired - Lifetime DE60239386D1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200100128 2001-01-25
DKPA200100679 2001-05-01
US30086301P 2001-06-27 2001-06-27
PCT/DK2002/000056 WO2002059297A2 (en) 2001-01-25 2002-01-25 A library of a collection of cells

Publications (1)

Publication Number Publication Date
DE60239386D1 true DE60239386D1 (de) 2011-04-21

Family

ID=43646216

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60239386T Expired - Lifetime DE60239386D1 (de) 2001-01-25 2002-01-25 Zellbibliothek

Country Status (9)

Country Link
US (2) US7838287B2 (de)
EP (1) EP1356037B1 (de)
JP (2) JP2004525624A (de)
AT (1) ATE501251T1 (de)
AU (1) AU2002227883A1 (de)
CA (1) CA2474172C (de)
DE (1) DE60239386D1 (de)
DK (1) DK1356037T3 (de)
WO (1) WO2002059297A2 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60239386D1 (de) 2001-01-25 2011-04-21 Evolva Ltd Zellbibliothek
US8008459B2 (en) 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
DE60324385D1 (de) * 2002-01-25 2008-12-11 Evolva Ag Screeningmethoden nach mehreren parametern und entwicklung von zellen, um kleine moleküle mit mehreren funktionalitäten zu produzieren
ES2368733T3 (es) 2002-07-18 2011-11-21 Merus B.V. Producción recombinante de mezclas de anticuerpos.
USRE47770E1 (en) 2002-07-18 2019-12-17 Merus N.V. Recombinant production of mixtures of antibodies
US20060252156A1 (en) * 2002-08-01 2006-11-09 Evolva Ltd. C/O Dr. Iur. Martin Eisenring Methods of mixing large numbers of heterologous genes
CA2527694C (en) 2003-05-30 2015-07-14 Hendricus Renerus Jacobus Mattheus Hoogenboom Fab library for the preparation of anti vegf and anti rabies virus fabs
US20100069614A1 (en) 2008-06-27 2010-03-18 Merus B.V. Antibody producing non-human mammals
EP1737971B1 (de) * 2004-01-20 2017-08-16 Merus N.V. Gemische bindender proteine
AU2006227165B2 (en) 2005-03-18 2011-11-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
WO2008042338A2 (en) 2006-09-28 2008-04-10 Microbia, Inc. Production of carotenoids in oleaginous yeast and fungi
KR101881596B1 (ko) 2008-12-02 2018-07-24 웨이브 라이프 사이언시스 재팬 인코포레이티드 인 원자 변형된 핵산의 합성 방법
KR101153866B1 (ko) 2009-05-21 2012-06-27 대한민국 형질전환용 운반체, 이의 제조방법, 이를 이용한 형질전환방법 및 형질전환체
SG177564A1 (en) 2009-07-06 2012-02-28 Ontorii Inc Novel nucleic acid prodrugs and methods of use thereof
EP2571991A1 (de) 2010-05-20 2013-03-27 Evolva SA Verfahren zur herstellung von isoprenoidverbindungen in hefe
NZ708078A (en) 2010-06-02 2017-01-27 Evolva Nutrition Inc Recombinant production of steviol glycosides
WO2012039448A1 (ja) 2010-09-24 2012-03-29 株式会社キラルジェン 不斉補助基
EP2734208B1 (de) 2011-07-19 2017-03-01 Wave Life Sciences Ltd. Verfahren zur synthese von funktionalisierten nukleinsäuren
CA3128532A1 (en) 2011-08-08 2013-02-14 Evolva Sa Recombinant production of steviol glycosides
MX360109B (es) 2012-04-20 2018-10-23 Merus Nv Metodos y medios para la produccion de moleculas de tipo ig.
US10829772B2 (en) 2012-06-22 2020-11-10 Monsanto Technology Llc Unique modular vector design
KR102213609B1 (ko) 2012-07-13 2021-02-08 웨이브 라이프 사이언시스 리미티드 키랄 제어
EP2872485B1 (de) 2012-07-13 2020-12-16 Wave Life Sciences Ltd. Asymmetrische hilfsgruppe
WO2014010718A1 (ja) 2012-07-13 2014-01-16 株式会社新日本科学 キラル核酸アジュバント
WO2014066374A1 (en) * 2012-10-22 2014-05-01 Refactored Materials, Inc. Cellular reprogramming for product optimization
CA3171770A1 (en) 2013-02-06 2014-08-14 Evolva Sa Methods for improved production of rebaudioside d and rebaudioside m
US10017804B2 (en) 2013-02-11 2018-07-10 Evolva Sa Efficient production of steviol glycosides in recombinant hosts
EP3046585B1 (de) 2013-09-17 2021-08-25 Bolt Threads, Inc. Verfahren und zusammensetzungen zur synthetisierung verbesserter seidenfasern
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
WO2015108047A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
JPWO2015108048A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
JPWO2015108046A1 (ja) 2014-01-15 2017-03-23 株式会社新日本科学 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
AU2015207773B2 (en) 2014-01-16 2021-06-17 Wave Life Sciences Ltd. Chiral design
BR112017002783A2 (pt) 2014-08-11 2017-12-19 Evolva Sa produção de glicosídeos de esteviol em hospedeiros recombinantes
MY191735A (en) 2014-09-09 2022-07-13 Evolva Sa Production of steviol glycosides in recombinant hosts
EP4148137A1 (de) 2015-01-30 2023-03-15 Evolva SA Herstellung von steviolglycosiden in rekombinanten wirten
CA2979931A1 (en) 2015-03-16 2016-09-22 Dsm Ip Assets B.V. Udp-glycosyltransferases
WO2017025362A1 (en) 2015-08-07 2017-02-16 Evolva Sa Production of steviol glycosides in recombinant hosts
US10982249B2 (en) 2016-04-13 2021-04-20 Evolva Sa Production of steviol glycosides in recombinant hosts
CN109312378A (zh) 2016-05-16 2019-02-05 埃沃尔瓦公司 在重组宿主中产生甜菊醇糖苷
KR20190046993A (ko) 2016-09-14 2019-05-07 볼트 쓰레즈, 인크. 긴 균일한 재조합 단백질 섬유
CN110100006A (zh) 2016-11-07 2019-08-06 埃沃尔瓦公司 重组宿主中甜菊糖苷的生产
WO2024075756A1 (ja) * 2022-10-05 2024-04-11 株式会社Logomix 細胞ライブラリおよびその製造方法
JP7212982B1 (ja) * 2022-10-05 2023-01-26 株式会社Logomix 細胞ライブラリおよびその製造方法

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341116C (en) 1983-02-22 2000-10-17 Rae Lyn Burke Yeast expression systems with vectors having gapdh or pyk promoters and synthesis or foreign protein
DE68920319D1 (de) 1988-04-22 1995-02-09 Massachusetts Inst Technology Verfahren zum formen und zum gebrauch von mikrotröpchen.
EP0481008B1 (de) 1989-07-07 1997-11-12 Unilever Plc Verfahren zur herstellung eines proteins mittels eines durch mehrfachkopieintegrierung eines expressionsvektors transformierten pilzes
US5316922A (en) 1992-04-15 1994-05-31 The United States Of America As Represented By Department Of Health And Human Services Method for indentifying and expressing proteins that recognize and adhere to specific probes
US5482845A (en) 1993-09-24 1996-01-09 The Trustees Of Columbia University In The City Of New York Method for construction of normalized cDNA libraries
ATE397066T1 (de) 1993-10-27 2008-06-15 Univ Columbia Methode zur bildung einer subtrahierten cdna bank und ihre verwendung
US6268140B1 (en) 1994-02-03 2001-07-31 Neugenesis Combinatorial metabolic libraries
US6165793A (en) 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US6309883B1 (en) 1994-02-17 2001-10-30 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
CA2219136A1 (en) 1995-04-24 1996-10-31 Chromaxome Corp. Methods for generating and screening novel metabolic pathways
US6030779A (en) 1995-07-18 2000-02-29 Diversa Corporation Screening for novel bioactivities
US6004788A (en) 1995-07-18 1999-12-21 Diversa Corporation Enzyme kits and libraries
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
US6057103A (en) 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
US20010041333A1 (en) 1997-06-16 2001-11-15 Short Jay M. High throughput screening for a bioactivity or biomolecule
US6537776B1 (en) 1999-06-14 2003-03-25 Diversa Corporation Synthetic ligation reassembly in directed evolution
US20030215798A1 (en) 1997-06-16 2003-11-20 Diversa Corporation High throughput fluorescence-based screening for novel enzymes
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
GB9603803D0 (en) * 1996-02-22 1996-04-24 Zeneca Ltd Production of proteins, plasmids coding therefor and organisms containing such plasmids
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6242211B1 (en) 1996-04-24 2001-06-05 Terragen Discovery, Inc. Methods for generating and screening novel metabolic pathways
US5783431A (en) 1996-04-24 1998-07-21 Chromaxome Corporation Methods for generating and screening novel metabolic pathways
AU2887897A (en) 1996-05-21 1997-12-09 Novo Nordisk A/S Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast
US5763239A (en) 1996-06-18 1998-06-09 Diversa Corporation Production and use of normalized DNA libraries
US6294325B1 (en) * 1996-07-05 2001-09-25 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of thermostable multi genes and proteins and uses thereof
JP2000515011A (ja) 1996-07-09 2000-11-14 アメリカ合衆国 形質転換関連組換えクローニング
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
CA2276064C (en) 1997-01-17 2013-12-17 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
CA2282658C (en) 1997-02-27 2003-02-25 Cellomics, Inc. A system for cell-based screening
EP0975969A4 (de) 1997-03-18 2002-07-31 Chromaxome Corp Screening-methode für verbindungen mit hilfe eingekapselter zellen
WO1998054339A1 (en) 1997-05-27 1998-12-03 Hanil Synthetic Fiber Co., Ltd. PROCESS FOR PREPARING RECOMBINANT PROTEINS USING HIGHLY EFFICIENT EXPRESSION VECTOR FROM $i(SACCHAROMYCES CEREVISIAE)
GB9727512D0 (en) 1997-12-31 1998-02-25 Adprotech Plc Fuzzy genes and their application in molecular adjuvants
WO1999045154A1 (en) 1998-03-04 1999-09-10 Diversa Corporation Production and use of normalized dna libraries
AU5217599A (en) 1998-07-27 2000-02-21 Genotypes, Inc. Automatic eukaryotic artificial chromosome vector
DE69931497T2 (de) 1998-08-07 2007-05-03 Cellay LLC, Cambridge Gel mikrotropfen für die genetische analyse
AU5696899A (en) 1998-08-31 2000-03-21 Maxygen, Inc. Transformation, selection, and screening of sequence-shuffled polynucleotides for development and optimization of plant phenotypes
EP1114320A2 (de) 1998-09-18 2001-07-11 Cellomics, Inc. Ein system für zellbasierte reihenuntersuchungen
AU3879300A (en) 1999-03-09 2000-09-28 Diversa Corporation End selection in directed evolution
JP2004500019A (ja) 1999-03-26 2004-01-08 ディベルサ　コーポレーション 定方向進化におけるエキソヌクレアーゼ仲介核酸再集合
GB9908814D0 (en) * 1999-04-16 1999-06-09 Celltech Therapeutics Ltd Process
AU7646000A (en) 1999-11-05 2001-05-14 Novozymes A/S Methods to screen microorganisms or gene libraries for products secreted from a cell
WO2001073000A2 (en) 2000-03-24 2001-10-04 Maxygen, Inc. Methods for modulating cellular and organismal phenotypes
AU2002226307A1 (en) 2001-01-25 2002-08-06 Evolva Biotech A/S Artificial chromosomes comprising concatemers of expressible nucleotide sequences
ATE375394T1 (de) 2001-01-25 2007-10-15 Evolva Ltd Concatemere unterschiedlich exprimierter multipler gene
DK1364005T3 (da) 2001-01-25 2009-02-02 Evolva Ltd En metode til udvikling af en celle der har en önsket fænotype og udviklede celler
US8008459B2 (en) 2001-01-25 2011-08-30 Evolva Sa Concatemers of differentially expressed multiple genes
DE60239386D1 (de) 2001-01-25 2011-04-21 Evolva Ltd Zellbibliothek
DE60324385D1 (de) 2002-01-25 2008-12-11 Evolva Ag Screeningmethoden nach mehreren parametern und entwicklung von zellen, um kleine moleküle mit mehreren funktionalitäten zu produzieren
ATE386810T1 (de) 2002-06-14 2008-03-15 Dyax Corp Rekombination von nukleinsäurebibliotheksmitgliedern
US20030235823A1 (en) 2002-06-24 2003-12-25 The University Of Alabama Nucleotide sequences that code for torsin genes, torsin proteins, and methods of using the same to treat protein-aggregation
US20060252156A1 (en) 2002-08-01 2006-11-09 Evolva Ltd. C/O Dr. Iur. Martin Eisenring Methods of mixing large numbers of heterologous genes

Also Published As

Publication number Publication date
US20040241672A1 (en) 2004-12-02
EP1356037A2 (de) 2003-10-29
WO2002059297A8 (en) 2004-04-15
AU2002227883A1 (en) 2002-08-06
ATE501251T1 (de) 2011-03-15
WO2002059297A2 (en) 2002-08-01
US7838287B2 (en) 2010-11-23
JP4965625B2 (ja) 2012-07-04
US20120094870A1 (en) 2012-04-19
JP2010043108A (ja) 2010-02-25
DK1356037T3 (da) 2011-06-27
WO2002059297A3 (en) 2003-04-10
EP1356037B1 (de) 2011-03-09
JP2004525624A (ja) 2004-08-26
CA2474172A1 (en) 2002-08-01
CA2474172C (en) 2012-07-10

Similar Documents

Publication Publication Date Title
ATE501251T1 (de) Zellbibliothek
Tang et al. LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis
Montavon et al. Chromatin organization and global regulation of Hox gene clusters
Perino et al. Chromatin control of developmental dynamics and plasticity
Mochida et al. Statistical and machine learning approaches to predict gene regulatory networks from transcriptome datasets
Mao et al. Discovery of scmR as a global regulator of secondary metabolism and virulence in Burkholderia thailandensis E264
Cohen et al. Histone modifiers in cancer: friends or foes?
Pawson et al. Network medicine
King et al. Mutagenic analysis of the destruction signal of mitotic cyclins and structural characterization of ubiquitinated intermediates.
Friedman et al. Epigenomics and the structure of the living genome
Feng et al. Accessing the inaccessible: the organization, transcription, replication, and repair of heterochromatin in plants
Corradi et al. Computational techniques are valuable tools for the discovery of protein–protein interaction inhibitors: the 14-3-3σ case
Wu et al. Long noncoding RNA and protein abundance in lncRNPs
DE60315723D1 (de) Herstellung von Polyketiden und anderen natürlichen Produkten
Zhalnina et al. Need for laboratory ecosystems to unravel the structures and functions of soil microbial communities mediated by chemistry
Oomen et al. Epigenetic characteristics of the mitotic chromosome in 1D and 3D
Pirrotta The necessity of chromatin: a view in perspective
Liu et al. Small molecule therapeutics targeting F-box proteins in cancer
Wong et al. Deciphering combinatorial genetics
Taha et al. Synthesis, molecular docking study and thymidine phosphorylase inhibitory activity of 3-formylcoumarin derivatives
Palumbo et al. Kinetics effects and modeling of mRNA turnover
Olsman et al. There's (still) plenty of room at the bottom
Chin Programming and engineering biological networks
Heng The genomic landscape of cancers
Wucherpfennig et al. Genetic screens to study the immune system in cancer

Legal Events

Date Code Title Description
R081 Change of applicant/patentee

Ref document number: 1356037

Country of ref document: EP

Owner name: EVOLVA LTD., CH

Free format text: FORMER OWNER: EVOLVA LTD., ALLSCHWIL, CH

Effective date: 20110705